-+ 0.00%
-+ 0.00%
-+ 0.00%

AGOMAB THERAPEUTICS NV - AGMB-447 SHOWS FAVORABLE SAFETY AND TOLERABILITY PROFILE AT 4.5 MG BID IN IPF PATIENTS

路透·09/14/2026 20:05:01

登录查看新闻详情